
In September 2025, the FDA approved Stellest lenses for children ages 6 to 12 to correct and manage myopia, a major milestone for myopia care. These lenses have been successfully used in countries across Europe, Canada, and Asia since 2020, showing promising results in slowing eye growth associated with myopia.
Myopia typically begins in early childhood, often between the ages of 6 and 10, and tends to worsen quickly during the school years as children spend more time reading and using digital devices. The sooner it begins, the higher the risk that it will progress to more severe levels. Every increase in myopia level significantly raises the risk of eye health complications later in life, such as retinal detachment or glaucoma.
By beginning myopia management as soon as possible, parents can help slow eye growth and protect long-term vision. With innovative options like Stellest lenses, families now have effective, science-backed solutions to take control of their child’s myopia.
Stellest lenses are a groundbreaking innovation in myopia control, developed by Essilor. They look like regular eyeglass lenses but are designed with specialized optical technology to both correct vision and slow the progression of myopia.